A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma

Survivin is a microtubule-associated protein believed to be involved in preserving cell viability and regulating tumor cell mitosis, and it is overexpressed in many primary tumor types, including melanoma. YM155 is a first-in-class survivin suppressant. The purpose of this Phase 2 study was to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudchadkar, Ragini, Ernst, Scott, Chmielowski, Bartosz, Redman, Bruce G, Steinberg, Joyce, Keating, Anne, Jie, Fei, Chen, Caroline, Gonzalez, Rene, Weber, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430257/
https://www.ncbi.nlm.nih.gov/pubmed/25533314
http://dx.doi.org/10.1002/cam4.363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430257/
https://www.ncbi.nlm.nih.gov/pubmed/25533314
http://dx.doi.org/10.1002/cam4.363

Ejemplares similares